Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases

Restricted access

Object. Cushing disease is a rare disorder. Because of their small size the adrenocorticotropic hormone (ACTH)—producing tumors are often not detectable on neuroimaging studies. To obtain a cure with transsphenoidal surgery (TSS) may therefore be difficult. In this report the authors present 10 years of experience in the treatment of patients with Cushing disease who were followed up with the same protocol and treated by the same surgeon.

Methods. Thirty-four patients, 26 of them female and eight of them male (mean age 40 years, range 13–74 years) were studied. All had obvious clinical signs and symptoms of Cushing syndrome. Magnetic resonance (MR) imaging was performed in all patients, and inferior petrosal sinus (IPS) sampling was done in 14.

In 12 patients MR imaging indicated a pituitary tumor; 10 were microadenomas and two were macroadenomas. In six patients with no visible tumor, the results of IPS sampling supported the diagnosis. All patients underwent TSS; the mean follow-up duration was 6 ± 0.5 years. Selective adenomectomy was performed in 32 and hemihypophysectomy in the other two patients. A cure was obtained in 31 patients (91%) after one TSS and in two more patients after further TSS; one patient was not cured despite two TSSs and one underwent bilateral adrenalectomy. Disease recurrence was seen in two patients after 3 years, and they were successfully treated with stereotactic gamma knife surgery. Half of the patients had an ACTH deficiency postoperatively, whereas one third had other pituitary hormone insufficiencies. There were no serious complications attributable to the surgical intervention.

Conclusions. Transsphenoidal surgery with selective adenomectomy is an effective and safe treatment for Cushing disease. In the patients presented in this study, the surgical outcome seemed to depend on careful preoperative evaluation and the surgeon's experience. For optimal results in this rare disease the authors therefore suggest that the endocrinological, radiological, and surgical procedures be coordinated in a specialized center.

Article Information

Address reprint requests to: Charlotte Höybye, M.D., Ph.D., Department of Endocrinology and Diabetology, Karolinska Hospital, SE-171 76 Stockholm, Sweden. email: charlotte.hoybye@ks.se.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Intraoperative photograph of the isolated left cavernous sinus (arrow), which has been isolated from the pituitary capsule, viewed through the operating microscope. The pituitary gland was dissected medially by using a 2-mm suction tube and a blunt dissector.

  • View in gallery

    Graph showing percentage of patients in remission of the 31 patients with Cushing disease per 1-year follow-up interval after one transsphenoidal operation.

References

  • 1.

    Bang PWiwall ILEricsson Uet al: Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol 124:6206291991Bang P Wiwall IL Ericsson U et al: Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol 124:620–629 1991

  • 2.

    Bochicchio DLosa MBuchfelder Met al: Factors influencing the immediate and late outcome of Cushing's Disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80:311431201995Bochicchio D Losa M Buchfelder M et al: Factors influencing the immediate and late outcome of Cushing's Disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80:3114–3120 1995

  • 3.

    Boscaro MSonino NScarda Aet al: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87:366236662002Boscaro M Sonino N Scarda A et al: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87:3662–3666 2002

  • 4.

    Bulow BHagmar LMikoczy Zet al: Increased cardiovascular mortality in patients with hypopituitarism. Clin Endocrinol 46:75811997Bulow B Hagmar L Mikoczy Z et al: Increased cardiovascular mortality in patients with hypopituitarism. Clin Endocrinol 46:75–81 1997

  • 5.

    Burke CWAdams CBEsiri MMet al: Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol 33:5255371990Burke CW Adams CB Esiri MM et al: Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol 33:525–537 1990

  • 6.

    Chen JCTAmar APChoi Set al: Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98:9679732003Chen JCT Amar AP Choi S et al: Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98:967–973 2003

  • 7.

    Dal Bo Zanon RFornasiero LBoscaro Met al: Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol Int Mag Klin Morphol Blutforsch 110:2682771983Dal Bo Zanon R Fornasiero L Boscaro M et al: Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol Int Mag Klin Morphol Blutforsch 110:268–277 1983

  • 8.

    Dickerman RDOldfield EH: Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97:134313492002Dickerman RD Oldfield EH: Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97:1343–1349 2002

  • 9.

    Friedman RBOldfield EHNieman LKet al: Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg 71:5205271989Friedman RB Oldfield EH Nieman LK et al: Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg 71:520–527 1989

  • 10.

    Guilhaume BBertagna XThomsen Met al: Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long-term follow-up studies. J Clin Endocrinol Metab 66:105610641988Guilhaume B Bertagna X Thomsen M et al: Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long-term follow-up studies. J Clin Endocrinol Metab 66:1056–1064 1988

  • 11.

    Hilding AHall KWivall-Hilleryd ILet al: Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19–82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:201320191999Hilding A Hall K Wivall-Hilleryd IL et al: Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency aged 19–82 years in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013–2019 1999

  • 12.

    Höybye CGrenbäck ERähn Tet al: Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:2842922001Höybye C Grenbäck E Rähn T et al: Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–292 2001

  • 13.

    Lamberts SWJvan der Lely AJde Herder WW: Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease. Considerations concerning preoperative medical treatment and the long-term follow-up. J Clin Endocrinol Metab 80:311131131995Lamberts SWJ van der Lely AJ de Herder WW: Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease. Considerations concerning preoperative medical treatment and the long-term follow-up. J Clin Endocrinol Metab 80:3111–3113 1995

  • 14.

    Lindholm JJuul SJorgensen JOLet al: Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:1171232001Lindholm J Juul S Jorgensen JOL et al: Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117–123 2001

  • 15.

    Massoud AFPowell MWilliams RAet al: Transsphenoidal surgery for pituitary tumours. Arch Dis Child 76:3984041997Massoud AF Powell M Williams RA et al: Transsphenoidal surgery for pituitary tumours. Arch Dis Child 76:398–404 1997

  • 16.

    McCance DRRussell CFKennedy TLet al: Bilateral adrenalectomy: low mortality in Cushing's disease. Clin Endocrinol 39:3153211993McCance DR Russell CF Kennedy TL et al: Bilateral adrenalectomy: low mortality in Cushing's disease. Clin Endocrinol 39:315–321 1993

  • 17.

    Melby JC: Therapy of Cushing's disease: a consensus for pituitary microsurgery. Ann Intern Med 109:4454461988Melby JC: Therapy of Cushing's disease: a consensus for pituitary microsurgery. Ann Intern Med 109:445–446 1988

  • 18.

    Morange-Ramos IRegis JDufour Het al: Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir 140:4374431998Morange-Ramos I Regis J Dufour H et al: Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir 140:437–443 1998

  • 19.

    Obuobie KDavies JSOgunko Aet al: Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest 23:5425442000Obuobie K Davies JS Ogunko A et al: Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest 23:542–544 2000

  • 20.

    Oldfield EH: Cushing disease. J Neurosurg 98:9489512003Oldfield EH: Cushing disease. J Neurosurg 98:948–951 2003

  • 21.

    Oldfield EHDoppman JLNieman LKet al: Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing syndrome. N Engl J Med 325:8979051991Oldfield EH Doppman JL Nieman LK et al: Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing syndrome. N Engl J Med 325:897–905 1991

  • 22.

    Park YGChang JWKim EYet al: Gamma knife surgery in pituitary microadenomas. Yonsei Med J 37:1651731996Park YG Chang JW Kim EY et al: Gamma knife surgery in pituitary microadenomas. Yonsei Med J 37:165–173 1996

  • 23.

    Rosén TEdén SLarsson Get al: Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 129:1952001993Rosén T Edén S Larsson G et al: Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 129:195–200 1993

  • 24.

    Semple CGThomson JATeasdale GM: Transsphenoidal microsurgery for Cushing's disease. Clin Endocrinol 21:6216291984Semple CG Thomson JA Teasdale GM: Transsphenoidal microsurgery for Cushing's disease. Clin Endocrinol 21:621–629 1984

  • 25.

    Semple PLVance MLFindling Jet al: Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery 46:5535592000Semple PL Vance ML Findling J et al: Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan. Neurosurgery 46:553–559 2000

  • 26.

    Sjöberg HEBlomback MGranberg PO: Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 199:95981976Sjöberg HE Blomback M Granberg PO: Thromboembolic complications heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 199:95–98 1976

  • 27.

    Toms GCMcCarthy MINiven MJet al: Predicting relapse after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 76:2912941993Toms GC McCarthy MI Niven MJ et al: Predicting relapse after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 76:291–294 1993

  • 28.

    Trainer PJLawrie HSVerhelst Jet al: Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 38:73781993Trainer PJ Lawrie HS Verhelst J et al: Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 38:73–78 1993

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 62 62 12
Full Text Views 115 115 0
PDF Downloads 107 107 0
EPUB Downloads 0 0 0

PubMed

Google Scholar